Targacept finishes recruiting for Alzheimer's trial

Targacept has recruited the patients it needs for a Phase 2b clinical study of a drug it hopes will become a treatment for Alzheimer's disease.

http://www.bizjournals.com/triad/blog/2013/04/targacept-finishes-recruiting-for.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_45+%28Semiconductor+Industry+News%29